Rapport Therapeutics to participate in upcoming investor conferences
Rapport Therapeutics says it will participate in upcoming investor conferences, a clinical-stage biotech focused on small molecule precision medicines.
BOSTON and SAN DIEGO, Sept.
02, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc.
NASDAQ:RAPP (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorde…